News and Articles - Arthramid

Arthramid in the joint

Filter:

Chance's Arthramid testimonial

How Arthramid Helped a Rescued Pony Rewrite His Future

The Myth of Neurotoxicity: What the Science Really Says About 2.5% iPAAG

The Myth of Neurotoxicity: What the Science Really Says About 2.5% iPAAG

jill Haas, Western rider

A Game Changer for Western Performance Horses

Retrospective analysis of the long-term use of 2.5% injectable polyacrylamide hydrogel (2.5% iPAAG) in a Thoroughbred racehorse practice: Safety on 701 horses, Efficacy on 214 horses

Retrospective analysis of the long-term use of 2.5% injectable polyacrylamide hydrogel (2.5% iPAAG) in a Thoroughbred racehorse practice: Safety on 701 horses, Efficacy on 214 horses

Retrospective analysis of the long-term use of 2.5% iPAAG in sport horse practice: Safety on 1000 horses, efficacy on 252 horses

Retrospective analysis of the long-term use of 2.5% iPAAG in sport horse practice: Safety on 1000 horses, efficacy on 252 horses

Tendon sheath study

Histopathologic Study of Intrasynovial Injection of the Equine Digital Flexor Tendon Sheath (DFTS) with 2.5% Polyacrylamide Hydrogel (2.5% iPAAG)

arthramid for stifle

A Second Chance: How Arthramid Gave Ciao Bella a New Lease on Life

Arthramid packaging

Arthramid 2.5% iPAAG: A Game-Changer for Joint Disease. A Vet’s Guide to Accessing It Legally in Europe.

arthramid for stifle

Joint Spotlight: The Stifle

Joint Spotlight: The Hock

Canine Arthramid testimonial

Fighting Canine Arthritis: How Arthramid Gave Sophie a New Lease on Life

Physicochemical Properties of 2.5% iPAAG

The Unique Physicochemical Properties of 2.5% Injectable Polyacrylamide Hydrogel (iPAAG) in Joint Lameness Treatment

READ

Listen to our Podcasts

Hear authentic stories from veterinary experts who advocate the success of Arthramid. Available on all major podcast platforms

Listen Now

An Introduction to Arthramid 2.5 iPAAG - Arthramid 2.5% iPAAG is a pioneering treatment setting a new standard in arthritic care for animals. Rather than simply mask pain, it defies conventional treatments by restoring freedom of movement through its advanced gel, acting as a bio-scaffold that bonds with the injured tissue.

This second episode in our series Dr Leigh de Clifford and Dr Jason Lowe discuss what sets Arthramid apart from other hydrogels, how it works and how veterinarians can use Arthramid in the management of joint lameness and osteoarthritis in horses.

Equine Veterinarian Dr Marc Koene talks Arthramid - "A major game changer in orthopaedic treatment" is how Dr Marc Koene describes Arthramid.

In Episode 4 of our series we meet with Dr Aziz Tnibar, another of the original researcher's behind the use of 2.5% iPAAG in the treatment of lameness and osteoarthritis in animals.

We talk to Australian legend Dr Kim McKellar, Equine Veterinarian, about his experiences of Arthramid from over 50 years in clinical practice; "I wish I had this product 30 years ago"

Dr Leigh de Clifford discusses the Published Literature to date for the development of the use of 2.5% iPAAG in treating lameness

In this episode we talk to Dr Leigh de Clifford, clinical veterinarian and published author, about where he finds Arthramid most useful in practice.

Dr Florent David and Australian Vet Association present Arthramid 2.5% iPAAG - This audio is from a presentation that was part of the Australian Veterinary Association Vet Fest Marketplace 2021.

The use of 2.5% injectable iPAAG in equine sports medicine. This episode is a recording of a webinar run by the Australian Veterinarian Association in which Dr Jason Lowe, Dr Stuart Vallance and Dr Marc Koene present the lastest research and findings on Arthramid

Intra-Articular Approaches to Osteoarthritis with Dr Lisa Fortier - Tune into esteemed researcher and veterinarian, Dr Lisa Fortier who, alongside Dr Jason Lowe, discussed Intra-Articular Approaches to Osteoarthritis and management of the disease in equines and companion animals at a recent seminar.

Dr Jason Lowe sits down with Dr Becci Ireland of Central Lakes Equine to discuss her experience with Arthramid, how she got on to it, some of her most memorable cases in using it and how she speaks to her clients about Arthramid.

Long-Term Use of 2.5% iPAAG in Performance Horses. This episode is a recording of a webinar run in partnership with VetPD and Contura Vet in April 2025. Join Dr Leigh de Clifford, Dr JD Conway, Dr Megan Green, and Dr Jason Lowe as they dive into the long-term use of 2.5% injectable polyacrylamide hydrogel (iPAAG) in equine performance horses.

Practical Applications of 2.5% iPAAG: An Imaging Perspective. Tune into the recording of a VetPD x Contura Vet panel discussion; The Practical Applications of 2.5% iPAAG: An Imaging Perspective with Dr Lea Walker and Dr Cooper Williams

Join Dr. Matt Brunke, DVM, DACVSMR, as he presents “It's Not the Cartilage, It's the Synovium”, a deep dive into the evolving understanding of canine osteoarthritis. In this informative session, Dr. Brunke explores the critical role the synovium plays in the pathophysiology of osteoarthritis, modern approaches to diagnosis, and a review of current evidence-based intra-articular (IA) therapies.

Interested in talking to us and learning more?

Send us a message and we will get in touch

BOOK NOW